Ling Lin

1.1k citations
12 papers · 819 indexed · 1 hit paper · h-index 10
Topics
Immune Cell Function and Interaction (5 papers)Immune cells in cancer (2 papers)Cancer, Hypoxia, and Metabolism (1 paper)

In The Last Decade

Ling Lin

12 papers receiving 811 citations

Hit Papers

CCL18 from Tumor-Associated Macrophages Promotes Breast C...20112026201620212011100200300400500

Peers

Ling Lin
Comparison fields: 5 of 73
  • Immunology 398
  • Molecular Biology 366
  • Oncology 333
  • Cancer Research 197
  • Pulmonary and Respiratory Medicine 73
Replace Elizabeth K. Duperret with:
Elizabeth K. Duperret United States
Won Jong Jin United States
Zhuoshun Yang China
Courtney B. Betts United States
Hitoe Torisu Japan
Dagmar Gotthardt Austria
Sophie Degouve France
Rebecca S. Moreci United States
Chunling Ma China
Wenjun Mou China
Ling Lin relative to Elizabeth K. Duperret United States Elizabeth K. Duperret's profile →
Citations per field
00.5×1.5×
Elizabeth K. Duperret · 1×
Citations per year

Countries citing papers authored by Ling Lin

Since Specialization
Citations

This map shows the geographic impact of Ling Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling Lin more than expected).

Fields of papers citing papers by Ling Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ling Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling Lin. The network helps show where Ling Lin may publish in the future.

Co-authorship network of co-authors of Ling Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Ling Lin. A scholar is included among the top collaborators of Ling Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ling Lin. Ling Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
#WorkIndexed citations
1 2
2 14
3 6
4 20
5 13
6 23
7 121
8 31
9 49
10 11
11 22
12
CCL18 from Tumor-Associated Macrophages Promotes Breast Cancer Metastasis via PITPNM3breakdown →
507

About Ling Lin

Ling Lin is a scholar working on Cancer Research, Immunology and Oncology, having authored 12 papers that have together received 819 indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (5 papers), Immune cells in cancer (2 papers) and Cancer, Hypoxia, and Metabolism (1 paper). The work is most often cited by research in Immunology (398 citations), Cancer Research (197 citations) and Oncology (333 citations). Ling Lin has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Herui Yao, Chang Gong, Fengyan Yu, Jianing Chen, Fengxi Su, Mark E. Ewen, Bodu Liu, Karen S. Anderson, Hui Deng and Fengsong Wang. Their work appears in journals such as Cancer Cell, Cancer and Current Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026